Israel Biotech Fund
Sarit Steinberg is the General Counsel & Chief Operating Officer at Israel Biotech Fund. Sarit Steinberg is a specialized executive in corporate operations and legal affairs, with a proven track record in cross-border mergers & acquisitions and commercial transactions. She has years of experience representing companies as in-house counsel and as an associate in a law firm in the high-tech and biotech sectors. Sarit completed her higher education in London, England (Queen Mary College, LL.B. (Hons.), London School of Economics, LL.M. Corporate Law (Hons. Merit).
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.